Practice Management News

KANSAS CITY, Missouri — To achieve true justice in kidney health care, clinicians must identify disparities in practice and develop a sustainable plan to address them, according to a presenter at the Annual Dialysis Conference.

The Consolidated Appropriations Act of 2023, enacted on Dec. 29, 2022, includes the Secure 2.0 Act of 2022, which contains many provisions designed to expand retirement coverage, increase retirement savings and clarify retirement rules.

Because practice management systems and electronic health records originally were designed to support accurate billing for subsequent reimbursement, fundamental changes to practice patterns are slow to enter clinical practices.

Allowing nurse practitioners full practice authority may help diversify the workforce and increase access to primary care, according to experts, but there are many factors in the benefit-risk balance to consider.

Our third and final post in the series “Introduction to Taxation of Sales Proceeds” addresses the taxation of sale proceeds if a target practice is a partnership, including an LLC treated as a partnership.

The American Medical Association and 118 other medical societies, including the American College of Rheumatology, are urging CMS to finalize proposed rules aiming to reform prior authorization, according to a press release.

Offering a decision aid regarding conservative kidney management to patients with advanced kidney disease and their family led to increased discussion of the treatment option with providers, according to a study.

Most medical practices nationwide sponsor some type of qualified retirement plan (QRP), including 401(k)s, profit-sharing plans, defined benefit plans and hybrid plans. Most physicians do not realize that a growing area of liability for all businesses, including medical practices, relates to QRPs and how they are managed.

In the United States, there were more than 600 excess deaths among physicians from March 2020 to December 2021, according to a research letter published in JAMA Internal Medicine.

There has been a lot of attention about a proposed rule from the Federal Trade Commission that would prohibit many noncompetes. However, much of the discussion has been misleading, if not entirely wrong.